These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26917273)

  • 1. NMDA receptor antagonism by repetitive MK801 administration induces schizophrenia-like structural changes in the rat brain as revealed by voxel-based morphometry and diffusion tensor imaging.
    Wu H; Wang X; Gao Y; Lin F; Song T; Zou Y; Xu L; Lei H
    Neuroscience; 2016 May; 322():221-33. PubMed ID: 26917273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter injuries induced by MK-801 in a mouse model of schizophrenia based on NMDA antagonism.
    Xiu Y; Kong XR; Zhang L; Qiu X; Chao FL; Peng C; Gao Y; Huang CX; Wang SR; Tang Y
    Anat Rec (Hoboken); 2014 Aug; 297(8):1498-507. PubMed ID: 24788877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of gray matter atrophy following 6-hydroxydopamine lesion of the nigrostriatal system.
    Westphal R; Sumiyoshi A; Simmons C; Mesquita M; Wood TC; Williams SC; Vernon AC; Cash D
    Neuroscience; 2016 Oct; 334():166-179. PubMed ID: 27506141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin.
    Turner CP; DeBenedetto D; Ware E; Stowe R; Lee A; Swanson J; Walburg C; Lambert A; Lyle M; Desai P; Liu C
    Exp Brain Res; 2010 Mar; 201(3):479-88. PubMed ID: 19885653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice.
    Takagi S; Balu DT; Coyle JT
    Schizophr Res; 2015 Mar; 162(1-3):216-21. PubMed ID: 25592804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
    Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
    Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated injection of MK801: an animal model of schizophrenia?
    Eyjolfsson EM; Brenner E; Kondziella D; Sonnewald U
    Neurochem Int; 2006; 48(6-7):541-6. PubMed ID: 16517016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiprobe molecular imaging of an NMDA receptor hypofunction rat model for glutamatergic dysfunction.
    Kosten L; Verhaeghe J; Verkerk R; Thomae D; De Picker L; Wyffels L; Van Eetveldt A; Dedeurwaerdere S; Stroobants S; Staelens S
    Psychiatry Res Neuroimaging; 2016 Feb; 248():1-11. PubMed ID: 26803479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myelinated fiber loss in the corpus callosum of mouse model of schizophrenia induced by MK-801.
    Xiu Y; Kong XR; Zhang L; Qiu X; Gao Y; Huang CX; Chao FL; Wang SR; Tang Y
    J Psychiatr Res; 2015 Apr; 63():132-40. PubMed ID: 25748751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local NMDA receptor hypofunction evokes generalized effects on gamma and high-frequency oscillations and behavior.
    Lee J; Hudson MR; O'Brien TJ; Nithianantharajah J; Jones NC
    Neuroscience; 2017 Sep; 358():124-136. PubMed ID: 28676240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction.
    Xu L; Qiu X; Wang S; Wang Q; Zhao XL
    Neurosci Bull; 2019 Apr; 35(2):347-361. PubMed ID: 30569431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats.
    Manahan-Vaughan D; von Haebler D; Winter C; Juckel G; Heinemann U
    Hippocampus; 2008; 18(2):125-34. PubMed ID: 17924525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live rats.
    Daya RP; Bhandari JK; Hui PA; Tian Y; Farncombe T; Mishra RK
    Neuropharmacology; 2014 Feb; 77():325-33. PubMed ID: 24140927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.
    Barnes SA; Sawiak SJ; Caprioli D; Jupp B; Buonincontri G; Mar AC; Harte MK; Fletcher PC; Robbins TW; Neill JC; Dalley JW
    Int J Neuropsychopharmacol; 2014 Oct; 18(2):. PubMed ID: 25552430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity.
    Dzietko M; Felderhoff-Mueser U; Sifringer M; Krutz B; Bittigau P; Thor F; Heumann R; Bührer C; Ikonomidou C; Hansen HH
    Neurobiol Dis; 2004 Mar; 15(2):177-87. PubMed ID: 15006687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain structure alterations and cognitive impairment following repetitive mild head impact: An in vivo MRI and behavioral study in rat.
    Qin Y; Li GL; Xu XH; Sun ZY; Gu JW; Gao FB
    Behav Brain Res; 2018 Mar; 340():41-48. PubMed ID: 27498246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Characterization of Structural Brain Changes in Schizophrenia.
    Ediri Arachchi W; Peng Y; Zhang X; Qin W; Zhuo C; Yu C; Liang M
    Neurosci Bull; 2020 Oct; 36(10):1107-1122. PubMed ID: 32495122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats--a possible model for schizophrenia.
    Baier PC; Blume A; Koch J; Marx A; Fritzer G; Aldenhoff JB; Schiffelholz T
    Behav Brain Res; 2009 Dec; 205(1):96-101. PubMed ID: 19539658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities.
    Rujescu D; Bender A; Keck M; Hartmann AM; Ohl F; Raeder H; Giegling I; Genius J; McCarley RW; Möller HJ; Grunze H
    Biol Psychiatry; 2006 Apr; 59(8):721-9. PubMed ID: 16427029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.
    Mastropaolo J; Rosse RB; Deutsch SI
    Behav Brain Res; 2004 Aug; 153(2):419-22. PubMed ID: 15265637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.